Affiliation:
1. the Departments of Cardiology (N.J.S.), Medicine and Therapeutics (N.J.S., K.L.W.), and Ophthalmology (J.R.T.), University of Leicester (United Kingdom); and the Department of Cardiology (L.O., K.C.), Royal Hallamshire Hospital, Sheffield, United Kingdom.
Abstract
Background
The
ACE
gene is characterized by a polymorphism based on the presence (insertion [
I
]) or absence (deletion [
D
]) within intron 16 of a 287-basepair
alu
repeat sequence, resulting in three genotypes. Subsequent studies have produced conflicting findings. To further evaluate the association of the
ACE
I/D
genotype with MI risk, we carried out a meta-analysis of all the published studies.
Methods and Results
In total, 15 studies containing 3394 MI cases and 5479 control subjects were analyzed. The overall distribution of genotypes in the control subjects was 22.7%
II,
49.0%
ID,
and 28.3%
DD
. The mean odds ratio for MI for
DD
versus
ID/II
genotypes across all studies was 1.26 (95% CI, 1.15, 1.39;
P
<.0001). Pairwise odds ratios were 1.36 (95% CI, 1.19, 1.55) for
DD
and
II,
1.24 (95% CI, 1.11, 1.38) for
DD
and
ID,
and 1.09 (95% CI, 0.96, 1.23) for
ID
and
II.
The relative risk appeared to be increased in Japanese populations (2.55; 95% CI, 1.75, 3.70).
Conclusions
Within the limitations of the available data, the meta-analysis therefore supports an association of the
ACE D
allele with MI risk and strengthens the justification for further evaluation in appropriately powered studies.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine